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INTRODUCTION
Computed tomography enterography (CTE) has been vali-
dated as an important imaging tool for small bowel evalua-
tion over the recent years and has a clear established role as 
one of the primary diagnostic tools in the evaluation of pa-
tients with inflammatory bowel disease (IBD). CTE was first 
introduced by Raptopoulos et al.1 in 1997 as a modified ab-
dominopelvic CT examination to specifically examine the 
small bowel, particularly to evaluate the extent and severity of 
Crohn disease.
This technique consists of luminal distention by large vol-
ume of neutral or low density oral contrast agent and optimiz-
ed bowel wall enhancement by intravenously administered 
contrast agent to maximize conspicuity of small bowel path-
ology. Recently developed multidetector CT technique provi-
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des optimal multiplanar images by thin section scanning. 
Compared with endoscopic exams or barium studies, CTE has 
the ability to delineate both intestinal and extraintestinal pa-
thology.
Therefore, CTE is a noninvasive examination that offers im-
portant and relevant information in the diagnosis and man-
agement of patients with proven or suspected IBD such as Cr-
ohn disease, intestinal tuberculosis (TB), and intestinal Behcet 
disease (BD). This article will provide a review of CTE with 
procedural technique and imaging findings of each IBD. In 
addition, it will describe recent advances in radiation dose re-
duction, which is important in the follow-up of patients with 
Crohn disease.
TECHNIQUE
Luminal distention by oral contrast agent
An adequate luminal distention is prerequisite for CTE. Op-
timized luminal distention provides rapid and efficient lumi-
nal navigation, accurate detection and characterization of sm-
all bowel abnormalities. Patients drink approximately 1.0 to 
1.5 L of oral contrast over 45 to 60 minutes. There are various 
oral contrast agents to obtain the distention of small bowel 
loops.2 The negative contrast agent such as polyethylene glycol 
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solution (PEG), suspension of 0.1% barium sulphate and wa-
ter-methylcellulose solution is preferred because they allow 
better depiction of bowel wall enhancement. Water-methyl-
cellulose solution has been gradually replaced by PEG or sus-
pension of 0.1% barium sulphate. Our current protocol is 
summarized in Table 1.
In CTE, oral contrast agent is administered by the oral route. 
However, contrast infusion through nasojejunal tube may be 
performed. The CT imaging after total opacification of the 
small bowel by such infusion is called as CT enteroclysis. Al-
though the CT enteroclysis has better jejunal distention and 
higher specificity for detecting pathologic small bowel,2 there 
are unavoidable limitations such as patient’s discomfort relat-
ed with nasojejunal tube insertion and the increased radia-
tion dose.3 Therefore, CTE has become a more preferred im-
aging technique for evaluating IBD because of the superior 
patient compliance and procedural convenience.
CT imaging protocol
CTE imaging protocol is as follows in our institute. It was 
performed using multidetector CT (Sensation-16 or Sensa-
tion-64; Siemens Medical Systems, Erlangen, Germany). Intra-
venous contrast material (120 to 150 mL) (Omnipaque 300 
mg I/mL; Amersham Health Inc., Princeton, NJ, USA) was 
administered at a rate of 3 mL/sec. A bolus-tracking program 
was used to obtain singe enteric phase CT data after the intra-
venous injection of contrast agent. The region of interest cur-
sor for bolus tracking was placed in the descending aorta at 
the level of the first lumbar vertebra for real time serial moni-
toring. 
Acquisition of enteric phase images was commenced at 35 
seconds after the trigger (trigger threshold level, 100 Houn-
sfield unit [HU]). Axial and coronal images were reconstruct-
ed and transferred to a picture archiving and communication 
system for image interpretation (slice thickness of 3 mm, and 
a reconstruction interval of 3.0 mm).
CTE FINDINGS OF CROHN DISEASE
Crohn disease, one of the major subtypes of the idiopathic 
IBD, is characterized by chronic, transmural, often granulo-
matous, intestinal inflammation. The small bowel is involved 
in almost 80% of the cases, with ileocecal region affected in 
50%.4 Enteric involvement of Crohn disease tends to be trans-
mural, segmental, and usually discontinuous. Multifocal small 
bowel disease may present with areas of different activity, some 
areas with acute inflammatory, and others with fibrostenos-
ing disease.
As Crohn disease is a chronic and relapsing disease, multiple 
examinations are required to identify the status of the disease 
(e.g., the severity and activity), to evaluate the efficacy of cur-
rent therapy and to modulate the therapeutic strategy. In that 
point, CTE can be an appropriate technique that can be easily 
performed, well tolerated for patients, be reliable in compari-
son of repeated exams as well as operator-independent. How-
ever, the effective dose of radiation from CT is relatively high 
compared with other modalities, and thus, patients with IBD 
can be exposed to significantly harmful amount of diagnostic 
radiation, mainly as a result of repeated CT examinations.
Active inflammatory disease
Crohn disease has a variety of appearances at CTE depend-
ing on whether the activity is acute inflammatory or chronic 
fibrostenosing and whether there are complications such as 
fistula or abscess. On CTE, enteric findings such as mural hy-
perenhancement, bowel wall thickening, mural stratification 
and extraenteric findings such as engorged vasa recta (“comb 
sign”),5 and increased attenuation of the mesenteric fat are 
features of active inflammatory small bowel Crohn disease.6,7
Among these findings, combination of mural hyperenhan-
cement and bowel wall thickening is the most sensitive CTE 
findings suggesting the active inflammatory Crohn disease.7 
While early studies suggested that bowel wall thickness cor-
related best with disease activity,7,8 more recent studies have 
suggested that mural hyperenhancement may be a more sen-
sitive sign.9
Mural hyperenhancement refers to segmental hyperenhan-
cement of the small bowel wall compared with the adjacent 
small bowel loops (Figs. 1, 2).7,9 It is important to compare the 
bowel loops with similar degree of distension because normal 
Table 1. Technique of Computed Tomography Enterography
Patient preparation Avoid solid foods for 4 hours.
1,200-1,500 mL of PEG orally over 60 minutes.
20 mg Buscopan administered intramuscularly prior to scanning.
CT acquisition and postprocessing Multidetector CT scanner.
Intravenous contrast material (120-150 mL) administered at a rate of 3 mL/sec.
Bolus-tracking program: single enteric phase 35 seconds after the trigger (threshold level: 100 HU).
Automated 3-mm axial and coronal reformats generated and archived to PACS.
PEG, polyethylene glycol; CT, computed tomography; HU, Hounsfield unit; PACS, picture archiving and communication system.
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collapsed loops show greater attenuation than that of distend-
ed bowel loop. Quantitative measurement techniques have 
been used to objectively correlate mural hyperenhancement 
and bowel wall thickness with disease activity. Using a mural 
attenuation threshold of 109 HU and an abnormal to normal 
loop enhancement ratio of more than 1.3, CTE is highly corre-
lated with histologic findings of active disease. Visual assess-
ment, however, presents higher specificity than do quantitative 
measurements.9
Bowel wall thickening refers to wall thickness of greater 
than 3 mm in a distended bowel loop (Figs. 1-3). It is the most 
frequently observed CT finding in Crohn disease, presenting 
in up to 82% of patients.10
Mural stratification is visualization of the bowel wall layers 
on CT after intravenous contrast administration.6,7 Bilaminar 
mural stratification refers to mucosal hyperenhancement and 
decreased intramural attenuation. Trilaminar mural stratific-
ation refers to alternating areas of high and low attenuation 
due to mucosal and serosal hyperenhancement and low in-
tramural attenuation (Figs. 1, 2). The low intramural attenua-
tion can represent edema, inflammatory infiltrate, or fat. Mu-
ral stratification due to intramural edema is more indicative of 
active disease compared to a homogenously enhanced wall,8,11 
while the presence of intramural fat indicates a more chronic 
process.6 One thing to notice is that mural stratification is not 
specific for Crohn disease and may be seen with other small 
bowel inflammatory conditions, such as ischemia, ulcerative 
colitis, and radiation enteritis.10
Increased attenuation of the mesenteric fat is due to edema 
and engorgement of the vasa recta (Fig. 1). The ‘‘comb sign’’ 
A  B  
Fig. 1. Active inflammatory Crohn disease in a 28-year-old man. (A) Axial computed tomography enterography images demonstrate multifo-
cal segmental mural hyperenhancement and trilaminar mural stratification in the ileum (arrows), suggesting active disease. (B) Also note 
engorged vasa recta (arrowheads) and increased attenuation of the mesenteric fat (asterisk).
A  B  C  
Fig. 2. Active inflammatory Crohn disease with extraenteric complications in a 29-year-old man. (A) Coronal computed tomography en-
terography images demonstrate multifocal segmental stricture showing wall thickening, mural hyperenhancement and stratification (arrows), 
and engorged vasa recta, “comb sign” (circle). (B, C) Also noted a mesenteric abscess (arrowheads in B) adjacent to the enteroenteric fis-
tula (arrow in C).
*
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refers to engorged vasa recta that penetrate the bowel wall per-
pendicular to the bowel lumen, simulating the appearance of 
a comb (Fig. 2). Increased attenuation of the mesenteric fat in 
combination with the ‘‘comb’’ sign is the most specific CT fi-
nding for active Crohn disease.12 It correlates with clinically 
advanced, active, and extensive Crohn disease.5,11,12 The ‘‘comb 
sign’’ on CTE is also reported to be associated with higher C-
reactive protein levels12 and more intensive medication regime 
than for patients with normal vasculature.11
Fibrostenosing disease
It is important to differentiate active inflammatory small 
bowel strictures from fibrotic strictures in patients with Crohn 
disease, because the former are mostly managed medically 
whereas the latter may require surgical intervention (e.g., 
balloon dilation, strictureplasty, or resection).3 CTE signs of 
chronic fibrostenosing disease are strictures without mural hy-
perenhancement or other signs of active inflammation, sub-
mucosal fat deposition, sacculations, and fibrofatty prolifera-
tion (Fig. 4).6,13
In fibrostenosing Crohn disease, mural stratification may be 
absent because of the transmural fibrosis and/or muscular hy-
pertrophy and collagen deposition leading to a homogeneous 
and less-intense enhancement.10 Strictures may occur in pa-
tients with active inflammatory disease due to inflammation 
with edema and bowel spasm. However, strictures are more 
frequent with chronic fibrosis.14,15 Differential point is that a 
stricture in acute disease is manifested by mural hyperen-
hancement, more severe bowel wall thickening, and mural st-
ratification. Submucosal fatty deposition in the bowel wall is 
also considered chronic changes of Crohn disease.6 However, 
active inflammation and fibrosis often coexist in the same pa-
tient or even in the same affected bowel segments in Crohn 
disease.
As the mesenteric border of bowel is preferentially affected 
by the inflammatory process of Crohn disease, the bowel loops 
often exhibit asymmetric mural fibrosis and shortening. 
Eventually, asymmetric fibrosis of the bowel loops combined 
with the increase in intraluminal pressure during the peristal-
tic movements results in sacculation of the antimesenteric wall 
(Fig. 3A).16
Fibrofatty proliferation has been long recognized as a hall-
mark of Crohn disease (Fig. 3B). It extends from the mesen-
A  B  C  
Fig. 3. Crohn disease in a 31-year-old man. (A, B) Coronal computed tomography enterography images show pseudosacculation along the 
antimesenteric border of small bowel (arrowheads). (B) Fibrofatty proliferation is also demonstrated in the mesentery (circle). (C) Sinus tract 
arising in the terminal ileum (arrow) which shows mural hyperenhancement and stratification, suggesting active inflammatory disease, is 
also noted.
Fig. 4. Fibrostenosing Crohn disease in a 32-year-old man. Axial 
computed tomography enterography image shows a segmental 
stricture involving proximal ileal loop. Homogenous mural thicken-
ing is seen at the strictured segment without mural hyperenhan-
cement, suggesting fibrostenotic disease (arrow).
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teric attachment and partially covers the chronically inflam-
ed bowel loop. Recent studies suggest that the hypertrophied 
mesenteric fat might have a role—related to the fat’s capacity 
to produce tumor necrosis factor α—in sustaining the in-
flammatory process in Crohn disease.17
Extraenteric complications
The transmural inflammation of the bowel in Crohn disease 
coupled with increased intraluminal pressure proximal to the 
site of strictures can lead to extension of the inflammatory 
process across the serosal surface into the adjacent mesentery 
or structures. CTE has an important role in the evaluation of 
extraenteric complications of Crohn disease. The most com-
mon extraenteric complications include fistula, sinus tract, 
and abscess.15,18,19
Blind-ending inflammatory tracts form a sinus that can le-
ad to a fistula if it communicates with another structure or flu-
id cavity. On CTE, sinus (Fig. 3C) or fistula (Figs. 2B, C, 5) are 
demonstrated as tethering of bowel loops and visualization of 
linear, enhancing tracts with or without communication with 
adjacent structures such as peritoneal or retroperitoneal spac-
es, skin or adjacent organs, or bowel, respectively.20 The most 
common type of fistula in Crohn disease is a perianal fistula 
(Fig. 5B). Other types of fistulas in Crohn disease include en-
terocutaneous, rectovaginal, enterovaginal, and enterovesicu-
lar fistulas.19 CTE has a high sensitivity for diagnosing fistulas. 
A recent study reported that CTE correctly identifies the pres-
ence or absence of fistulae in 94% of patients.15 The improved 
detection of fistulas by CTE compared to earlier studies likely 
reflects the improved spatial resolution due to thinner slice 
collimation and higher quality multiplanar images.
Abscesses are easily detected by CTE which is usually con-
tiguous to the diseased bowel segment and is seen in the mes-
entery or retroperitoneal space (Fig. 2).6 The accurate detec-
tion of abscesses and fistulas has high importance not only 
because it affects the decision to treat medically or surgically, 
but also it can affect the method of surgical approach (lapa-
roscopic vs. open). A recent study by Bruining et al.21 showed 
that CTE affected on the physician’s level of confidence for the 
findings of active small bowel disease, fistula, abscess, or stric-
ture formation, which was altered in more than 90% of cases, 
with clinically significant changes in up to 77.6%. Booya et al.22 
also reported detection of clinically unsuspected penetrating 
disease on CTE examinations, leading to alteration in therapy 
in up to 61% of patients with Crohn disease.
Other extraenteric manifestations of Crohn disease, such as 
mesenteric lymphadenopathy, cholelithiasis, nephrolitiasis, sa-
croiliitis, and primary sclerosing cholangitis, can also be eval-
uated.6
Treatment response evaluation
CTE can also be used to assess treatment response in Crohn 
disease, which manifests as decreasing mural hyperenhance-
ment and bowel wall thickening, and improvement in the en-
gorged vasa recta.8,23,24 Hara et al.8 observed that CTE interpret-
ation of the disease progression or regression correlated with 
symptoms in 16/20 (80%) patients. Wu et al.23 reported that 
CTE findings have high correlation with clinical remission. 
According to their results, mural hyperenhancement and bo-
wel wall thickening, the most sensitive signs of active disease, 
were decreased significantly after effective therapy, using a 
combination of clinical, endoscopic, pathologic, and laborato-
ry findings as the criteria of disease remission. They also ob-
served that the pattern of mural stratification changed with the 
trend from trilaminar or bilaminar stratification with muco-
sal hyperenhancement toward homogenous or bilaminar 
stratification without mucosal hyperenhancement. In addi-
tion, CTE can be used in evaluating postoperative recurrence 
of Crohn disease, which is most frequently seen at or imme-
diately proximal to the anastomotic site.
CTE FINDINGS OF INTESTINAL TB
The diagnosis of intestinal TB remains a diagnostic chal-
A  B  
Fig. 5. Crohn disease in a 34-year-old woman. (A) Axial computed tomography enterography image shows enteroenteric fistula involving il-
eal loops (arrow). (B) Perianal fistula is also seen (arrow).
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lenge because it can mimic a lot of other disease entities, par-
ticularly Crohn disease. It is very difficult to differentiate in-
testinal TB from Crohn disease because they share similar 
clinical, pathological, and endoscopic findings.25 Although 
coexistence of pulmonary TB may be suggestive of small bow-
el TB, only 15% of cases of abdominal TB have evidence of 
pulmonary TB.26
Most frequent site of intestinal TB is ileocecal area (approxi-
mately 90% in case of gastrointestinal TB). CT may show cir-
cumferential wall thickening in the cecum and terminal ileum 
(Fig. 6). CT findings that may assist with the differentiation 
of intestinal TB from Crohn disease include short segmental 
inflammatory wall thickening related with the circumferen-
tial distribution of superficial ulcers (Fig. 7) in TB versus rel-
atively long segmental wall thickening related with the ec-
centric longitudinal distribution of ulcers in Crohn disease. In 
addition, incompetence of ileocecal valve appears to be com-
mon in TB but uncommon in Crohn disease (Fig. 8). Mural st-
ratification is known to be more frequent in Crohn disease.27
Among extraintestinal findings, the central low attenuated 
lymph nodes, indicative of caseous necrosis, is a favorable CT 
finding of TB (Fig. 8). Fibrofatty proliferation, positive comb 
sign by increased mesenteric vascularity and internal/peri-
anal fistula suggests the possibility of Crohn disease rather 
than intestinal TB. The CT findings for differential diagnosis 
between are summarized in Table 2. However, the differenti-
ation between intestinal TB and Crohn disease may be diffi-
cult because they sometimes share similar radiologic findings 
(Fig. 9).
Fig. 8. Intestinal tuberculosis in a 27-year-old woman. Axial com-
puted tomography enterography image shows enhanced wall 
thickening involving cecum and terminal ileum with patulous ileo-
cecal valve (arrows). Associated central low attenuated lymph 
nodes are seen at the ileocecal mesentery, suggesting caseous 
necrosis (arrowheads).
Fig. 7. Intestinal tuberculosis in a 52-year-old woman. Coronal com-
puted tomography enterography image shows two short segmental 
circumferential enhancing wall thickenings involving proximal ileal 
loop (arrows). Associated prestenotic bowel dilatation is also seen.
Fig. 6. Intestinal tuberculosis in a 37-year-old woman. Coronal 
computed tomography enterography image shows circumferential 
wall thickening in the ileocecal valve area (arrow). Such ileocecal 
involvement is the most common form of intestinal tuberculosis.
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BD is characterized by the histopathologic finding of non-
specific vasculitis in multiple organs. The diagnosis is usually 
made on the basis of the combination of clinical signs and symp-
toms. It involves the gastrointestinal tract in 10% to 50% of 
patients.28 The most commonly involved site in the gastroin-
testinal tract is the ileocecal area.29,30 Intestinal BD is diagnos-
ed by the presence of typical intestinal ulcers (a few round-sh-
aped, deep ulcers with discrete margins in the ileocecal area) 
and systemic symptoms meeting the BD diagnostic criteria.30 
The inflammation is transmural and extends to the serosa, 
manifested as the ulceration penetrating to the serosa or the 
fascia, with a tendency to irregularly undermine the tissue. On 
CTE, intestinal BD are commonly manifested as geographic, 
relatively large, and deep penetrating ulcer with bowel wall 
thickening and mural hyperenhancement in the ileocecal re-
gion (Figs. 9, 10). Occasionally, intestinal BD manifests as a 
cecal mass or an aneurysmal dilatation of the terminal ileum 
masquerading as a malignant tumor (Fig. 11).31,32 The under-
Fig. 9. Crohn disease mimicking intestinal tuberculosis in a 53-year-
old man. Relatively short segmental circumferential stricture is 
suspected in the distal ileal loop (arrow). Associated angulation is 
also seen. There is no remarkable finding in the mesentery. Pre-
operative computed tomography diagnosis was intestinal tuber-
culosis, but Crohn disease was confirmed after segmental resec-
tion of the small bowel loop.
Fig. 10. Behcet disease in a 53-year-old woman. Axial computed 
tomography enterography image shows focal wall thickening with a 
deep penetrating ulcer (arrowheads) in the terminal ileum, and 
mesenteric fat infiltration around the ileocecal area.
Table 2. Differential Diagnosis of Tuberculosis from Cronh Disease
Crohn disease Intestinal tuberculosis
Ileocecal involvement: may spare Very frequent
Mural thickening with stratification Mural thickening without stratification
Long eccentric involvement of inflammatory thickening (mesenteric border) 
  with antimesenteric pseudosaccultion
Short concentric inflammatory thickening
Mesenteric fibrofatty proliferation Rare
Increased mesenteric vascularity (comb sign) Rare
- Central necrosis lymphadenopathy
Internal fistula and perianal fistula: frequent Rare
334  Clin Endosc 2013;46:327-336
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mining tendency of ulcers often results in bowel perforation 
and hemorrhage. CTE has advantages in the evaluation of ex-
traluminal changes, contributing to early detection of compli-
cations such as perforation, fistula, hemorrhage, and perito-
nitis.31,32
In patients with intestinal BD, the frequency of postopera-
tive recurrence ranges from 40% to 80%.33,34 There are three 
types of recurrence: the most common type consists of one or 
two deep ulcers, the second most common type is multiple 
aphthous ulcers, and the least common type is enterocutane-
ous fistula.33 Most recurrent ulcers occur at or near the anasto-
mosis site (Fig. 12) and develop within 2 years after surgery.33 
Considering the high frequency of postoperative recurrence 
and the common recurrence site at or near the anastomosis 
site, CTE may also have an important role in the detection of 
postoperative recurrence and the differentiation from post-
operative complication.
Radiation dose reduction issue
Radiation concern is an important issue in CTE because 
patients with Crohn disease are relatively younger and are ex-
pected to undergo multiple follow-up CT studies.35 Desmond 
et al.36 reported that portion of CT scans contributing to cu-
mulative effective dose increased from 46.3% during the first 
5 years to 84.7% during the final 5 years in their 15-year study 
of patients with IBD. This increase is likely due to the in-
creased use of CT. In addition, a very recent study of Korean 
A  B  
Fig. 11. Behcet disease in a 41-year-old man. (A, B) Axial computed tomography enterography images show wall thickening and several 
large, deep ulcers (arrowheads in A) in the terminal ileum with aneurysmal dilatation (asterisk in B).
Fig. 12. Recurrent Behcet disease in a 30-year-old woman. Coronal 
computed tomography enterography image shows an ulceration 
with peripheral enhancement at the anastomosis site of ileocecec-
tomy (arrows).
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patients with IBD showed that 34.7% of patients with Crohn 
disease were exposed to harmful levels of radiation (cumula-
tive effective dose >50 mSv) and CT accounted for 81.6% of 
total effective dose.37 Therefore, radiation dose reduction tech-
nique should be applied in CTE image acquisition protocol. 
Various techniques have been developed to reduce the radia-
tion dose to the patient. First one is tube current (mA) modu-
lation, which modulates the mAs based on the body thickness 
of each individual patient with sustaining diagnostic image 
quality.38 Second one is tube potential modulation (kV). 
Lowering tube potential is effective for dose reduction. In ad-
dition, lowering kV typically leads to an increase in iodine 
contrast, which may be helpful for detecting enhanced in-
flammatory bowel thickening. However, it allows more noise. 
Therefore, lower dose with constant image quality (contrast 
noise ratio) is essential in application of lowering tube poten-
tial.39 New image reconstruction technique such as iterative 
reconstruction enables the noise reduction using CT projec-
tion data in the lowering kV setting. Kaza et al.40 reported that 
CTE at 80 kVp with iterative reconstruction can produce di-
agnostically acceptable image quality with effective dose, 4.6 
mSV, while the effective dose of routine CTE at 120 kVp was 
15.8 mSV. There are more important dose reduction strate-
gies apart from these advanced technologies. One is to mini-
mize the number of dynamic CT phases. Wold et al.41 reported 
that arterial phase imaging is not contributory for detection 
of active Crohn disease. Single-phase imaging at CTE is suf-
ficient in most cases of evaluation of Crohn disease (Fig. 13).
CONCLUSIONS
CTE allows the identification of intramural and extraintes-
tinal sign of IBD such as Crohn disease, intestinal TB, and in-
testinal BD. The specific findings of each disease may be help-
ful for the differential diagnosis and planning of treatment st-
rategy. CT dose reduction issue using several advanced tech-
niques is emphasized without compromising the diagnostic 
image quality.
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